Health care marketing may resemble retail as patients gain consumer savvy.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to N Peyser.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Consistent with managed health care and associated fundamental shifts in health care economics, physician group sizing has evolved from a formula-driven analytical exercise to one which necessarily addresses a series of strategic issues relative to critical mass, scale economies, and market demands. Strategic issues, therefore, will take priority over operational considerations in determining group size. The methodology proposed considers interactions between qualitative assumptions (group goals/philosophy, market share targets) and quantitative variables (market demographics, physician capacity, physician supply, utilization rates, etc.) within the context of overall group vision relative to the market. Included is a brief case study that applies the recommended approach and illustrates three important considerations in employing the methodology.
One third of all cases of the acquired immunodeficiency syndrome (AIDS) in the United States are associated with the injection of illicit drugs. There is mounting evidence for the effectiveness of syringe exchange programs in reducing human immunodeficiency virus (HIV) risk behavior and HIV transmission among injection drug users. Expansion of syringe exchange would require increased public funding and undoubtedly would include government regulation of syringe exchanges. An analogy is drawn with the present system of regulation of methadone maintenance treatment programs and possible regulation of syringe exchange programs. Specific recommendations are offered to reduce the likelihood of repeating the regulatory problems of methadone maintenance treatment in future regulation of syringe exchange programs.
Explore the source record for details and available documents.
The relationship between public policy and scientific investigation is explored by a review of the experience with methadone maintenance treatment for narcotic addiction. The implementation of a widespread treatment effort in Hong Kong in the 1970s is contrasted with recent policies in regard to methadone treatment expansion in the United States. In neither case did research findings form the basis for public policy. In Hong Kong, rapid expansion of methadone treatment was initiated before scientific evidence was available to support this course, and in the United States treatment expansion has been rejected despite extensive evidence of its utility and safety. Decisions by government officials and health care providers, as in the case of addiction treatment, may be influenced more by philosophy and intuition than by scientific evidence. Scientists must recognize and address this reality if they are to play a meaningful role in shaping public health policy.